2026 ICD-10-CM Diagnosis Code C22.1Intrahepatic bile duct carcinoma

ICD-10-CM CodesC00–D49C15-C26C22

ICD-10-CM C22.1
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C22.1 is a billable ICD-10-CM diagnosis code for intrahepatic bile duct carcinoma. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 435 through 437. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Gastrointestinal cancers - bile duct.

Code Identity

ICD-10-CM Code
C22.1
Billable Status
Yes — Valid for Submission
Code Describes
Intrahepatic bile duct carcinoma
Short Description
Intrahepatic bile duct carcinoma
Same as the full description in the CMS dataset.
Parent Code
Malignant neoplasm of liver and intrahepatic bile ducts

Code Classification

ChapterC00–D49Neoplasms
SectionC15-C26Malignant neoplasms of digestive organs
CategoryC22Malignant neoplasm of liver and intrahepatic bile ducts
This CodeC22.1Intrahepatic bile duct carcinoma

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Adenocarcinoma of liver and intrahepatic biliary tract
  • Cholangiocarcinoma of biliary tract
  • Cholangiocarcinoma of intrahepatic biliary tract
  • Intrahepatic bile duct carcinoma
  • Malignant neoplasm of interlobular bile ducts
  • Malignant neoplasm of intrahepatic bile duct
  • Malignant neoplasm of intrahepatic canaliculi
  • Metastatic cholangiocarcinoma
  • Primary adenocarcinoma of bile duct
  • Primary adenocarcinoma of intrahepatic bile duct
  • Primary carcinoma liver and/or biliary system
  • Primary carcinoma of bile duct
  • Primary cholangiocarcinoma of biliary tract
  • Primary cholangiocarcinoma of intrahepatic biliary tract
  • Primary cystadenocarcinoma of intrahepatic bile duct
  • Primary intrahepatic bile duct carcinoma
  • Primary malignant neoplasm of intrahepatic bile duct
  • Primary squamous cell carcinoma of liver and intrahepatic biliary tract
  • Primary undifferentiated carcinoma of liver and intrahepatic biliary tract
  • Squamous cell carcinoma of liver and intrahepatic biliary tract
  • Undifferentiated carcinoma of liver and intrahepatic biliary tract

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Cholangiocarcinoma

Type 1 Excludes

  • malignant neoplasm of hepatic duct C24.0

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Adenocarcinoma
      • bile duct type
    • Adenocarcinoma
      • bile duct type
        • liver
    • Adenocarcinoma
      • bile duct type
        • unspecified site
    • Cancer
      • bile duct type liver
    • Carcinoma(malignant)
      • bile duct
        • liver
    • Carcinoma(malignant)
      • bile duct
        • unspecified site
    • Cholangiocarcinoma
      • liver
    • Cholangiocarcinoma
      • unspecified site
    • Cystadenocarcinoma
      • bile duct

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO018
Gastrointestinal cancers - bile duct
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Metastatic Cholangiocarcinoma

    a cholangiocarcinoma that has metastasized to other anatomic sites.

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
bile or biliary (tract) canaliculi (biliferi) (intrahepatic)C22.1C78.7D01.5D13.4D37.6D49.0
bile or biliary (tract) canals, interlobularC22.1C78.89D01.5D13.4D37.6D49.0
bile or biliary (tract) duct or passage (common) (cystic) (extrahepatic) interlobularC22.1C78.89D01.5D13.4D37.6D49.0
bile or biliary (tract) duct or passage (common) (cystic) (extrahepatic) intrahepaticC22.1C78.7D01.5D13.4D37.6D49.0
canaliculi, biliary (biliferi) (intrahepatic)C22.1C78.7D01.5D13.4D37.6D49.0
cholangioleC22.1C78.89D01.5D13.4D37.6D49.0
gall duct (extrahepatic) intrahepaticC22.1C78.7D01.5D13.4D37.6D49.0
intrahepatic (bile) ductC22.1C78.7D01.5D13.4D37.6D49.0

Patient EducationClinical

Bile Duct Cancer

Your liver makes a digestive juice called bile. Your gallbladder stores it between meals. When you eat, your gallbladder pushes the bile into tubes called bile ducts. They carry the bile to your small intestine. The bile helps break down fat. It also helps the liver get rid of toxins and wastes.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C22.1 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
155.1 Mal neo intrahepat ducts
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C22.1Overview

Is C22.1 (Malignant neoplasm of liver and intrahepatic bile ducts) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report intrahepatic bile duct carcinoma on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C22.1 group to?

When intrahepatic bile duct carcinoma is the principal diagnosis on an inpatient stay, it groups to MS-DRG 435, 436, 437, with relative weights from 0.8533 to 1.8367 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of C22.1?

Under the General Equivalence Mappings, intrahepatic bile duct carcinoma converts to ICD-9-CM 155.1 (mal neo intrahepat ducts). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.